Motivation This paper addresses the challenge of incorporating 3-dimensional (3D) structural information in graph kernels for machine learning-based virtual screening, a crucial task in drug discovery. Existing kernels that capture 3D information often suffer from high computational complexity, which limits their scalability.Results To overcome this, we propose the 3D chain motif graph kernel, which effectively integrates essential 3D structural properties-bond length, bond angle, and torsion angle-within the three-hop neighborhood of each atom in a molecule. In addition, we introduce a more computationally efficient variant, the 3D graph hopper kernel (3DGHK), which reduces the complexity from the state-of-the-art O(n6) (for the 3D pharmacophore kernel) to O(n2(m+log(n)+delta 2+dT6)). Here, n is the number of nodes, T is the highest degree of the node, m is the number of edges, delta is the diameter of the graph, and d is the dimension of the attributes of the nodes. We conducted experiments on 21 datasets, demonstrating that 3DGHK outperforms other state-of-the-art 2D and 3D graph kernels, but it also surpasses deep learning models in classification accuracy, offering a powerful and scalable solution for virtual screening tasks.Availability and implementation Our code is publicly available at https://github.com/SantaAnkit/Efficient-3D-kernels-for-molecular-property-prediction.git.
MOTIVATION:T cell receptors (TCRs) are fundamental components of the adaptive immune system, recognizing specific antigens for targeted immune responses. Understanding their sequence patterns is crucial for designing effective vaccines and immunotherapies. However, the vast diversity of TCR sequences and complex binding mechanisms pose significant challenges in generating TCRs that are specific to a particular epitope. RESULTS:Here, we propose TCR-epiDiff, a diffusion-based deep learning model for generating epitope-specific TCRs and predicting TCR-epitope binding. TCR-epiDiff integrates epitope information during TCR sequence embedding using ProtT5-XL and employs a denoising diffusion probabilistic model for sequence generation. Using external validation datasets, we demonstrate the ability to generate biologically plausible, epitope-specific TCRs. Furthermore, we leverage the model's encoder to develop a TCR-epitope binding predictor that shows robust performance on the external validation data. Our approach provides a comprehensive solution for both de novo generation of epitope-specific TCRs and TCR-epitope binding prediction. This capability provides valuable insights into immune diversity and has the potential to advance targeted immunotherapies. AVAILABILITY AND IMPLEMENTATION:The data and source codes for our experiments are available at: https://github.com/seoseyeon/TCR-epiDiff.
MOTIVATION:Enzyme engineering is a critical approach for producing enzymes that meet industrial and research demands by modifying wild-type proteins to enhance properties such as catalytic activity and thermostability. Beyond traditional directed evolution and rational design, recent advancements in deep learning offer cost-effective and high-performance alternatives. By encoding implicit coevolutionary patterns, these pretrained models have become powerful tools, with the central challenge being to uncover the intricate relationships among protein sequence, structure, and function. RESULTS:We present VenusREM, a retrieval-enhanced protein language model designed to capture local amino acid interactions in both spatial and temporal scales. VenusREM achieves state-of-the-art performance on 217 assays from the ProteinGym benchmark. Beyond high-throughput open benchmark validations, we conducted a low-throughput post hoc analysis on more than 30 mutants to verify the model's ability to improve the stability and binding affinity of a VHH antibody. We also validated the effectiveness of VenusREM by designing 10 novel mutants of a DNA polymerase and performing wet-lab experiments to evaluate their enhanced activity at elevated temperatures. Both in silico and experimental evaluations not only confirm the reliability of VenusREM as a computational tool for enzyme engineering but also demonstrate a comprehensive evaluation framework for future computational studies in mutation effect prediction. AVAILABILITY AND IMPLEMENTATION:The implementation is available at https://github.com/tyang816/VenusREM.
MOTIVATION:Amyloid signaling sequences adopt the cross-β fold that is capable of self-replication in the templating process. Propagation of the amyloid fold from the receptor to the effector protein is used for signal transduction in the immune response pathways in animals, fungi, and bacteria. So far, a dozen of families of amyloid signaling motifs (ASMs) have been classified. Unfortunately, due to the wide variety of ASMs it is difficult to identify them in large protein databases available, which limits the possibility of conducting experimental studies. To date, various deep learning (DL) models have been applied across a range of protein-related tasks, including domain family classification and the prediction of protein structure and protein-protein interactions. RESULTS:In this study, we develop tailor-made bidirectional LSTM and BERT-based architectures to model ASM, and compare their performance against a state-of-the-art machine learning grammatical model. Our research is focused on developing a discriminative model of generalized ASMs, capable of detecting ASMs in large datasets. The DL-based models are trained on a diverse set of motif families and a global negative set, and used to identify ASMs from remotely related families. We analyze how both models represent the data and demonstrate that the DL-based approaches effectively detect ASMs, including novel motifs, even at the genome scale. AVAILABILITY AND IMPLEMENTATION:The models are provided as a Python package, asmscan-bilstm, and a Docker image at https://github.com/chrispysz/asmscan-proteinbert-run. The source code can be accessed at https://github.com/jakub-galazka/asmscan-bilstm and https://github.com/chrispysz/asmscan-proteinbert. Data and results are at https://github.com/wdyrka-pwr/ASMscan.
This editorial describes the review and selection process of full-length, original research papers submitted to the Proceedings track of the ISMB/ECCB 2025 conference.
SUMMARY:Drug-target affinity (DTA) prediction is an important regression task for drug discovery, which can provide richer information than traditional drug-target interaction prediction as a binary prediction task. To achieve accurate DTA prediction, quite large amount of data are required for each drug, which is not available as of now. Thus, data scarcity and sparsity is a major challenge. Another important task is "cold-start" DTA prediction for unseen drug or protein. In this work, we introduce MixingDTA, a novel framework to tackle data scarcity by incorporating domain-specific pretrained language models for molecules and proteins with our MEETA (MolFormer and ESM-based Efficient aggregation Transformer for Affinity) model. We further address the label sparsity and cold-start challenges through a novel data augmentation strategy named GBA-Mixup, which interpolates embeddings of neighboring entities based on the guilt-by-association (GBA) principle, to improve prediction accuracy even in sparse regions of DTA space. Our experiments on benchmark datasets demonstrate that the MEETA backbone alone provides up to a 19% improvement of mean squared error over current state-of-the-art baseline, and the addition of GBA-Mixup contributes a further 8.4% improvement. Importantly, GBA-Mixup is model-agnostic, delivering performance gains across all tested backbone models of up to 16.9%. Case studies shows how MixingDTA interpolates between drugs and targets in the embedding space, demonstrating generalizability for unseen drug-target pairs while effectively focusing on functionally critical residues. These results highlight MixingDTA's potential to accelerate drug discovery by offering accurate, scalable, and biologically informed DTA predictions. AVAILABILITY AND IMPLEMENTATION:The code for MixingDTA is available at https://github.com/rokieplayer20/MixingDTA.
MOTIVATION:Accurately predicting the impact of single-point mutations on protein stability is crucial for elucidating molecular mechanisms underlying diseases in life sciences and advancing protein engineering in biotechnology. With recent advances in deep learning and protein structure prediction, deep learning approaches are expected to surpass existing methods for predicting protein thermostability. However, structure-based deep learning models, specifically convolutional neural networks, are affected by orientation biases, leading to inconsistent predictions with respect to the input protein orientation. RESULTS:In this study, we present OrgNet, a novel orientation-gnostic deep learning model using 3D convolutional neural networks to predict protein thermostability change upon point mutation. OrgNet encodes protein structures as voxel grids, enabling the model to capture fine-grained, spatially localized atomic features. OrgNet implements spatial transforms to standardize input protein orientations, thus eliminating orientation bias problem. When evaluated on established benchmarks, including Ssym and S669, OrgNet achieves state-of-the-art performance, demonstrating superior accuracy and robust performance compared to existing methods. AVAILABILITY AND IMPLEMENTATION:OrgNet is available at https://github.com/i-Molecule/OrgNet.
MOTIVATION:Disruption in normal gene expression can contribute to the development of diseases and chronic conditions. However, identifying disease-specific gene signatures can be challenging due to the presence of multiple co-occurring conditions and limited sample sizes. Unsupervised representation learning methods, such as matrix decomposition and deep learning, simplify high-dimensional data into understandable patterns, but often do not provide clear biological explanations. Incorporating prior biological knowledge directly can enhance understanding and address small sample sizes. Nevertheless, current models do not jointly consider prior knowledge of molecular interactions and sample labels. RESULTS:We present GRACKLE, a novel nonnegative matrix factorization approach that applies Graph Regularization Across Contextual KnowLedgE. GRACKLE integrates sample similarity and gene similarity matrices based on sample metadata and molecular relationships, respectively. Simulation studies show GRACKLE outperformed other NMF algorithms, especially with increased background noise. GRACKLE effectively stratified breast tumor samples and identified condition-enriched subgroups in individuals with Down syndrome. The model's latent representations aligned with known biological patterns, such as autoimmune conditions and sleep apnea in Down syndrome. GRACKLE's flexibility allows application to various data modalities, offering a robust solution for identifying context-specific molecular mechanisms in biomedical research. AVAILABILITY AND IMPLEMENTATION:GRACKLE is available at: https://github.com/lagillenwater/GRACKLE.
MOTIVATION:The task of designing optimized messenger RNA (mRNA) sequences has received much attention in recent years, thanks to breakthroughs in mRNA vaccines during the COVID-19 pandemic. Because most previous work aimed to minimize the minimum free energy (MFE) of the mRNA in order to improve stability and protein expression, which only considers one particular structure per mRNA sequence, millions of alternative conformations in equilibrium are neglected. More importantly, we prefer an mRNA to populate multiple stable structures and be flexible among them during translation when the ribosome unwinds it. RESULTS:Therefore, we consider a new objective to minimize the ensemble free energy of an mRNA, which includes all possible structures in its Boltzmann ensemble. However, this new problem is much harder to solve than the original MFE optimization. To address the increased complexity of this problem, we introduce EnsembleDesign, a novel algorithm that employs continuous relaxation to optimize the expected ensemble free energy over a distribution of candidate sequences. EnsembleDesign extends both the lattice representation of the design space and the dynamic programming algorithm from LinearDesign to their probabilistic counterparts. Our algorithm consistently outperforms LinearDesign in terms of ensemble free energy, especially on long sequences. Interestingly, as byproducts, our designs also enjoy lower average unpaired probabilities (which correlates with degradation) and flatter Boltzmann ensembles (more flexibility between conformations). AVAILABILITY AND IMPLEMENTATION:Our code is available on: https://github.com/LinearFold/EnsembleDesign.
MOTIVATION:Drug repositioning, identifying new therapeutic applications for existing drugs, can significantly reduce the time and cost involved in drug development. Recent studies have explored the use of Anatomical Therapeutic Chemical (ATC) codes in drug repositioning, offering a systematic framework to predict ATC codes for a drug. The ATC classification system organizes drugs according to their chemical properties, pharmacological actions, and therapeutic effects. However, its complex hierarchical structure and the limited scalability at higher levels present significant challenges for achieving accurate ATC code prediction. RESULTS:We propose a novel approach to predict ATC codes of drugs, named Feature Aggregation and Convolution with Transformer models (FACT). This method computes three types of drug similarities, incorporating ATC code similarity with hierarchical weights and masked drug-ATC code associations. These features are then aggregated for each target drug-ATC code pair and processed through a convolution-transformer encoder to generate three embeddings. The embeddings are finally used to estimate the probability of an association between the target pair. The experimental results demonstrate that the proposed method achieves an area under the receiver operating characteristic curve (AUROC) of 0.9805 and an area under the precision-recall curve of 0.9770 at level 4 of the ATC codes, outperforming the previous methods by 15.05% and 18.42%, respectively. This study highlights the effectiveness of integrating diverse drug features and the potential of transformer-based models in ATC code prediction. AVAILABILITY AND IMPLEMENTATION:Source code of FACT is freely available at https://github.com/knhc1234/FACT.
MOTIVATION:Protein language models (PLMs) are amongst the most exciting recent advances for characterizing protein sequences, and have enabled a diverse set of applications, including structure determination, functional property prediction, and mutation impact assessment, all from single protein sequences alone. State-of-the-art PLMs leverage transformer architectures originally developed for natural language processing, and are pre-trained on large protein databases to generate contextualized representations of individual amino acids. To harness the power of these PLMs to predict protein-level properties, these per-residue embeddings are typically "pooled" to fixed-size vectors that are further utilized in downstream prediction networks. Common pooling strategies include Cls-Pooling and Avg-Pooling, but neither of these approaches can capture the local substructures and long-range interactions observed in proteins. RESULTS:We propose the use of attention pooling, which can naturally capture these important features of proteins. To make the expensive attention operator (quadratic in the length of the input protein) feasible in practice, we introduce bag-of-mer pooling, or BoM-Pooling, a locality-aware hierarchical pooling technique that combines windowed average pooling with attention pooling. We empirically demonstrate that both full attention pooling and BoM-Pooling outperform previous pooling strategies on three important, diverse tasks: (i) predicting the activities of two proteins as they are varied; (ii) detecting remote homologs; and (iii) predicting signaling protein interactions with peptides. Overall, our work highlights the advantages of biologically inspired pooling techniques in protein sequence modeling and is a step toward more effective adaptations of language models in biological settings. AVAILABILITY AND IMPLEMENTATION:https://github.com/Singh-Lab/bom-pooling.
MOTIVATION:Fine-grained cellular characterization provides critical insights into biological processes, including tissue development, disease progression, and treatment responses. The spatial organization of cells and the interactions among distinct cell types play a pivotal role in shaping the tumor micro-environment, driving heterogeneity, and influencing patient prognosis. While computational pathology can uncover morphological structures from tissue images, conventional methods are often restricted to identifying coarse-grained and limited cell types. In contrast, spatial transcriptomics-based approaches hold promise for pinpointing fine-grained transcriptional cell types using histology data. However, these methods tend to overlook key molecular signatures inherent in gene expression data. RESULTS:To this end, we propose a cross-modal unified representation learning framework (CUCA) for identifying fine-grained cell types from histology images. CUCA is trained on paired morphology-molecule spatial transcriptomics data, enabling it to infer fine-grained cell types solely from pathology images. Our model aims to harness the cross-modal embedding alignment paradigm to harmonize the embedding spaces of morphological and molecular modalities, bridging the gap between image patterns and molecular expression signatures. Extensive results across three datasets show that CUCA captures molecule-enhanced cross-modal representations and improves the prediction of fine-grained transcriptional cell abundances. Downstream analyses of cellular spatial architectures and intercellular co-localization reveal that CUCA provides insights into tumor biology, offering potential advancements in cancer research. AVAILABILITY AND IMPLEMENTATION:The source code of CUCA is available in Zenodo: 10.5281/zenodo.15087256.
MOTIVATION:The availability of large genotyped cohorts brings new opportunities for revealing the high-resolution genetic structure of admixed populations via local ancestry inference (LAI), the process of identifying the ancestry of each segment of an individual haplotype. Though current methods achieve high accuracy in standard cases, LAI is still challenging when reference populations are more similar (e.g. intra-continental), when the number of reference populations is too numerous, or when the admixture events are deep in time, all of which are increasingly unavoidable in large biobanks. RESULTS:In this work, we present Recomb-Mix, a new LAI method which integrates elements from the site-based Li and Stephens model and introduces a new graph collapsing techniques to simplify counting paths with the same ancestry label readout. Through comprehensive benchmarking on various simulated datasets, we show that Recomb-Mix is more accurate than existing methods in diverse sets of scenarios while being competitive in terms of resource efficiency. The scalability and robustness of Recomb-Mix are also demonstrated with real-world datasets. We expect that Recomb-Mix will be a useful method for advancing genetics studies of admixed populations. AVAILABILITY AND IMPLEMENTATION:The implementation of Recomb-Mix is available at https://github.com/ucfcbb/Recomb-Mix.
MOTIVATION:Discovering genetic variations underpinning brain disorders is important to understand their pathogenesis. Indirect associations or spurious causal relationships pose a threat to the reliability of biomarker discovery for brain disorders, potentially misleading or incurring bias in subsequent decision-making. Unfortunately, the stringent selection of reliable biomarker candidates for brain disorders remains a predominantly unexplored challenge. RESULTS:In this article, to fill this gap, we propose a fresh and powerful scheme, referred to as the Causality-aware Genotype intermediate Phenotype Correlation Approach (Ca-GPCA). Specifically, we design a bidirectional association learning framework, integrated with a parallel causal variable decorrelation module and sparse variable regularizer module, to identify trustworthy causal biomarkers. A disease diagnosis module is further incorporated to ensure accurate diagnosis and identification of causal effects for pathogenesis. Additionally, considering the large computational burden incurred by high-dimensional genotype-phenotype covariances, we develop a fast and efficient strategy to reduce the runtime and prompt practical availability and applicability. Extensive experimental results on four simulation data and real neuroimaging genetic data clearly show that Ca-GPCA outperforms state-of-the-art methods with excellent built-in interpretability. This can provide novel and reliable insights into the underlying pathogenic mechanisms of brain disorders. AVAILABILITY AND IMPLEMENTATION:The software is publicly available at https://github.com/ZJ-Techie/Ca-GPCA.
MOTIVATION:Protein-protein interactions (PPIs) are fundamental aspects in understanding biological processes. Accurately predicting the effects of mutations on PPIs remains a critical requirement for drug design and disease mechanistic studies. Recently, deep learning models using protein 3D structures have become predominant for predicting mutation effects. However, significant challenges remain in practical applications, in part due to the considerable disparity in generalization capabilities between easy and hard mutations. Specifically, a hard mutation is defined as one with its maximum TM-score <0.6 when compared to the training set. Additionally, compared to physics-based approaches, deep learning models may overestimate performance due to potential data leakage. RESULTS:We propose new training/test splits that mitigate data leakage according to the CATH homologous superfamily. Under the constraints of physical energy, protein 3D structures, and CATH domain objectives, we employ a hybrid noise strategy as data augmentation and present a geometric encoder scenario, named CATH-ddG, to represent the mutational microenvironment differences between wild-type and mutated protein complexes. Additionally, we fine-tune ESM2 representations by incorporating a lightweight nonlinear module to achieve the transferability of sequence co-evolutionary information. Finally, our study demonstrates that CATH-ddG framework provides enhanced generalization by outperforming other baselines on non-superfamily leakage splits, which plays a crucial role in exploring robust mutation effect regression prediction. Independent case studies demonstrate successful enhancement of binding affinity on 419 antibody variants to human epidermal growth factor receptor 2 (HER2) and 285 variants in the receptor-binding domain (RBD) of SARS-CoV-2 to angiotensin-converting enzyme 2 (ACE2) receptor. AVAILABILITY AND IMPLEMENTATION:CATH-ddG is available at https://github.com/ak422/CATH-ddG.
SUMMARY:Recent breakthroughs in AI-driven generative models enable the rapid design of extensive molecular libraries, creating an urgent need for fast and accurate drug-likeness evaluation. Traditional approaches, however, rely heavily on structural descriptors and overlook pharmacokinetic (PK) factors such as absorption, distribution, metabolism, and excretion (ADME). Furthermore, existing deep-learning models neglect the complex interdependencies among ADME tasks, which play a pivotal role in determining clinical viability. We introduce ADME-DL (drug likeness), a novel two-step pipeline that first enhances diverse range of molecular foundation models (MFMs) via sequential ADME multi-task learning. By enforcing an A→D→M→E flow-grounded in a data-driven task dependency analysis that aligns with established PK principles-our method more accurately encodes PK information into the learned embedding space. In Step 2, the resulting ADME-informed embeddings are leveraged for drug-likeness classification, distinguishing approved drugs from negative sets drawn from chemical libraries. Through comprehensive experiments, our sequential ADME multi-task learning achieves up to +2.4% improvement over state-of-the-art baselines, and enhancing performance across tested MFMs by up to +18.2%. Case studies with clinically annotated drugs validate that respecting the PK hierarchy produces more relevant predictions, reflecting drug discovery phases. These findings underscore the potential of ADME-DL to significantly enhance the early-stage filtering of candidate molecules, bridging the gap between purely structural screening methods and PK-aware modeling. AVAILABILITY AND IMPLEMENTATION:The source code for ADME-DL is available at https://github.com/eugenebang/ADME-DL.
